Clinical trials recruiting for Resectable Pancreatic Ductal Adenocarcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Azenosertib | 1 |
| Cobimetinib | 1 |
| Gallium Ga 68 FAPi-46 | 1 |
| Genetic Testing | 1 |
| Olaparib | 1 |
| Onvansertib | 1 |
| Samuraciclib | 1 |
| Saruparib | 1 |
| Tremelimumab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Georgia | 1 |
| Minnesota | 1 |
| Oregon | 1 |
| Washington | 1 |
Top cities
Self-screener
Recruiting trials
- Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
- Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma
- Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer
- Targeted Pathway Inhibition in Patients With Pancreatic Cancer
- Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment
Related conditions
Trials recruiting for Resectable Pancreatic Ductal Adenocarcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Resectable Pancreatic Ductal Adenocarcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.